FDA approves Vertex’s acute pain treatment Journavx
The US Food and Drug Administration (FDA) has approved Vertex Pharmaceuticals’ oral Journavx (suzetrigine) to treat adults ...
FDA approves new painkiller that shows promise and challenges of opioid alternatives
The U.S. Food and Drug Administration said it approved Vertex Pharmaceuticals’ Journavx for short-term pain that often follows surgery or injuries.
The American Journal of Managed Care8h
Suzetrigine: First-in-Class Non-Opiate Pain Therapy is Approved by FDA
Suzetrigine (Journavx) is the first new drug approved to treat acute pain in over 20 years and the first to be classified as ...
Nursing in Practice14h
CPD: Preventing diabetes complications
GP Dr Roger Henderson provides an overview of the chronic complications of diabetes and the key preventive measures ...
Ever-Growing USA on MSN14h
Arialief Reviews 2025 (Consumer Report Analysis) Is This Supplement Good For Sciatic Nerve Pain Relief?
Arialief is a comprehensive nerve health supplement that specifically targets sciatic nerve pain and claims to provide ...